CompletedNCT06276790Updated Feb 26, 2024

Objective Analysis of Caesarean Scar Pregnancy

An observational study in Caesarean Scar Pregnancy and Ultrasound Scoring System, sponsored by Chengde Central Hospital. Completed at 1 site in China. Open to female participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2024-02-26.

Sponsored by Chengde Central Hospital · Observational

Study type: Observational
Model: Case-control
Time perspective: Retrospective
Enrollment: 117
Ages: 20 Years and older
Sex: Female

Study summary

This study uses a systematic scoring method combined with clinical and ultrasound data to comprehensively evaluate patient conditions and explore the guiding value of the ultrasound quantitative scoring system for selecting the surgical approach for caesarean scar pregnancy.

Conditions studied

Caesarean Scar Pregnancy
Ultrasound Scoring System

In context

Lead sponsor

This is the only study on the registry with Chengde Central Hospital as lead sponsor.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 20 Years and older
Sexes eligible: Female
Sampling method: Non-probability sample

Study population

A total of 117 patients with caesarean scar pregnancy admitted to the Obstetrics and Gynecology Inpatient Area of Chengde Central Hospital, China, from January 2019 to December 2022 were selected for this study.

Inclusion criteria

history of at least one previous caesarean section
symptoms suggestive of caesarean scar pregnancy, such as unexplained abnormal vaginal bleeding, abdominal pain, cervical pain or abnormal uterine activity during pregnancy
amenorrhea ≤84 days
ultrasound examination suggesting a single gestational sac with intact morphology
stable maternal vital signs

Exclusion criteria

Exclusion Criteria:

mass-type caesarean scar pregnancy
previous medication or surgical treatment before ultrasound examination
haemodynamically unstable patients
patients with surgical contraindications
incomplete or lost follow-up clinical data
patients with severe medical conditions such as hypertension, diabetes, hyperthyroidism and haemophilia

Study design

Observational model: Case-control
Time perspective: Retrospective
Enrollment: 117 participants (actual)
Patient registry: No

Groups and cohorts

low-risk group
Procedure: ultrasound-guided/hysteroscopic curettage
high-risk group
Procedure: Procedure/Surgery: laparoscopic removal of the pregnancy lesion

Interventions

Procedureultrasound-guided/hysteroscopic curettage
ultrasound-guided/hysteroscopic curettage
ProcedureProcedure/Surgery: laparoscopic removal of the pregnancy lesion
laparoscopic removal of the pregnancy lesion

What researchers measure

Primary outcomes

intraoperative blood loss
The patient's blood loss during surgery. Check the blood volume in ml of the aspirator reservoir.
Time frame: during surgery
length of hospital stay
Number of days the patient was hospitalized. Discharge assessment: vital signs stable, no abdominal pain, no active bleeding.
Time frame: Within 1 week
serum β-HCG levels
The time taken for serum β-HCG levels to return to normal
Time frame: Within 2 weeks after the operation

Study locations

1 site

Chengde Central Hospital
Chengde, 067000, China

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Feb 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT06276790
Lead sponsor: Chengde Central Hospital
Responsible party: Jianwen Du (physician, Chengde Central Hospital) — Principal investigator
First posted: Feb 26, 2024
Start date: Jan 18, 2019
Primary completion: Dec 23, 2022
Completion: Dec 25, 2022
Last update: Feb 26, 2024

Oversight

FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion